227 related articles for article (PubMed ID: 10364350)
1. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.
Schell TD; Mylin LM; Georgoff I; Teresky AK; Levine AJ; Tevethia SS
J Virol; 1999 Jul; 73(7):5981-93. PubMed ID: 10364350
[TBL] [Abstract][Full Text] [Related]
2. Control of advanced choroid plexus tumors in SV40 T antigen transgenic mice following priming of donor CD8(+) T lymphocytes by the endogenous tumor antigen.
Schell TD; Tevethia SS
J Immunol; 2001 Dec; 167(12):6947-56. PubMed ID: 11739514
[TBL] [Abstract][Full Text] [Related]
3. In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.
Schell TD
J Virol; 2004 Feb; 78(4):1751-62. PubMed ID: 14747540
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.
Mylin LM; Schell TD; Roberts D; Epler M; Boesteanu A; Collins EJ; Frelinger JA; Joyce S; Tevethia SS
J Virol; 2000 Aug; 74(15):6922-34. PubMed ID: 10888631
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen.
Mylin LM; Deckhut AM; Bonneau RH; Kierstead TD; Tevethia MJ; Simmons DT; Tevethi SS
Virology; 1995 Apr; 208(1):159-72. PubMed ID: 11831696
[TBL] [Abstract][Full Text] [Related]
6. Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.
Mylin LM; Bonneau RH; Lippolis JD; Tevethia SS
J Virol; 1995 Nov; 69(11):6665-77. PubMed ID: 7474076
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope.
Ryan CM; Schell TD
J Immunol; 2006 Jul; 177(1):255-67. PubMed ID: 16785521
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors.
Tatum AM; Mylin LM; Bender SJ; Fischer MA; Vigliotti BA; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2008 Sep; 181(6):4406-17. PubMed ID: 18768900
[TBL] [Abstract][Full Text] [Related]
9. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.
Schell TD; Knowles BB; Tevethia SS
Cancer Res; 2000 Jun; 60(11):3002-12. PubMed ID: 10850449
[TBL] [Abstract][Full Text] [Related]
10. Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors.
Yorty JL; Tevethia SS; Schell TD
Cancer Immunol Immunother; 2008 Jun; 57(6):883-95. PubMed ID: 18004562
[TBL] [Abstract][Full Text] [Related]
11. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
[TBL] [Abstract][Full Text] [Related]
12. Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants.
Tevethia SS; Lewis M; Tanaka Y; Milici J; Knowles B; Maloy WL; Anderson R
J Virol; 1990 Mar; 64(3):1192-200. PubMed ID: 1689391
[TBL] [Abstract][Full Text] [Related]
13. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
Lukacher AE; Wilson CS
J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430
[TBL] [Abstract][Full Text] [Related]
14. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
Newmaster RS; Mylin LM; Fu TM; Tevethia SS
Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
[TBL] [Abstract][Full Text] [Related]
15. Frequency analysis of simian virus 40-specific cytotoxic T lymphocyte precursors in the high responder C57BL/6 mouse strain.
Jennings SR; Fresa KL; Lippe PA; Milici JE; Tevethia SS
J Gen Virol; 1988 Oct; 69 ( Pt 10)():2493-503. PubMed ID: 2459302
[TBL] [Abstract][Full Text] [Related]
16. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
17. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
Hudrisier D; Oldstone MB; Gairin JE
Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
[TBL] [Abstract][Full Text] [Related]
18. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
[TBL] [Abstract][Full Text] [Related]
19. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL.
Wilson CS; Moser JM; Altman JD; Jensen PE; Lukacher AE
J Immunol; 1999 Apr; 162(7):3933-41. PubMed ID: 10201912
[TBL] [Abstract][Full Text] [Related]
20. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.
Fu TM; Mylin LM; Schell TD; Bacik I; Russ G; Yewdell JW; Bennink JR; Tevethia SS
J Virol; 1998 Feb; 72(2):1469-81. PubMed ID: 9445050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
